Nitric oxide synthase 2 genetic variation rs2297514 associates with a decreased susceptibility to extremity post-traumatic osteomyelitis in a Chinese Han population.

BACKGROUND

Previous studies have indicated that nitric oxide synthase 2 () genetic variations are involved in delayed fracture healing and fracture non-union. Whether these genetic variants associate with the development of osteomyelitis (OM) remains unclear. Here, we analyzed the potential relationships between genetic variations and the risk of developing post-traumatic OM (PTOM) in a Chinese Han population.

METHODS

Altogether 704 participants, including 336 PTOM patients and 368 healthy controls, were genotyped of rs2297514 and rs2248814 of the gene using the SNaPshot genotyping method.

RESULTS

Outcomes showed that the frequency of allele C of rs2297514 in the patient group was significantly lower than that in the control group (48.7% . 54.5%, = 0.029, OR = 0.792, 95% CI 0.642 - 0.976). In addition, significant associations were found between rs2297514 and susceptibility to PTOM by the recessive model ( = 0.007, OR = 0.633, 95% CI 0.453 - 0.884), and the homozygous model ( = 0.039, OR = 0.648, 95% CI 0.429 - 0.979). Moreover, patients with the CC genotype of rs2297514 had lower inflammatory biomarkers levels than the TT genotype, especially for the C-reactive protein (CRP) level (median: 4.1 mg/L . 8.9 mg/L, = 0.027). However, no significant relationship was noted between rs2248814 and the risk of developing PTOM.

CONCLUSION

In this Chinese cohort, rs2297514 is correlated with a decreased risk of PTOM development, with genotype CC as a protective factor.